GlassScriptPhysician profile
Aman Shamaa
NPI 1902326739
$7,764.14
in general payments reported to CMS, 2019-2025
52 companies · $2,781 in 2025
The $2,781 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.75 · 2022: $786 · 2023: $2,544 · 2024: $1,566 · 2025: $2,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,080 · Education: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,079.58 |
| Education | $811.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,026.83 | 2022-2025 | Tezspire, Tagrisso, Lynparza |
| Myriad Genetic Laboratories, INC. | $882.77 | 2023 | Precisetumor, Mychoice Cdx |
| Janssen Biotech, INC. | $825.29 | 2023-2025 | Darzalex, Tecvayli, Carvykti |
| Astellas Pharma US INC | $798.55 | 2023-2025 | Vyloy, Xospata, Xtandi |
| Daiichi Sankyo INC. | $614.33 | 2023-2025 | Enhertu, Injectafer |
| Aveo Pharmaceuticals, INC. | $434.27 | 2023-2025 | Fotivda |
| Abbvie INC. | $413.62 | 2021-2025 | |
| Glaxosmithkline, LLC. | $404.03 | 2022-2025 | Zejula, Jemperli, Ojjaara |
| Incyte Corporation | $155.20 | 2025 | Jakafi, Niktimvo, Jakafi |
| Emd Serono, INC. | $153.21 | 2022-2024 | |
| Seagen INC. | $146.98 | 2022-2023 | Tivdak |
| Novartis Pharmaceuticals Corporation | $144.42 | 2023-2025 | |
| Beigene USA, INC. | $124.99 | 2023 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $113.04 | 2024-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Beone Medicines USA, INC. | $109.66 | 2025 | Tevimbra |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Shamaa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.